Pharmaceutical Policy

In an update to past discussion of pharmaceutical policy, and the questionable efficacy of high-cost, patented medications, The Guardian provides insight into how drug companies manage to get such favorable results in studies of the efficacy of their products. Common techniques include avoiding any head-to-head comparisons with other medications (as opposed to testing against a placebo), comparing a new medication with an inadequate or excessive dose of a competing product, and, most frequently, conducting a trial that is too small to produce results which might prove a competing product to be superior.

Comments